Loading
Adult stem cell institute undertakes ambitious campaign for cures
Dr. Alan Moy, MD, Scientific Director of John Paul II Stem Cell Research Institute
Dr. Alan Moy, MD, Scientific Director of John Paul II Stem Cell Research Institute
By Benjamin Mann
Facebook Twitter Google+ Pinterest Addthis

.- With pro-life ethics and a patient-driven paradigm, the John Paul II Stem Cell Research Institute hopes to save lives and shape the future of medicine.

“Medical research is becoming too expensive and taking too long. It's not transformative enough, or impacting patients at a fast enough rate,” institute founder and director Dr. Alan Moy told CNA on Feb. 10, explaining the motivation behind his ambitious “Collection For Cures” project.

“It's more than just doing ethical research. We had to come up with a new paradigm,” Moy said of his institute's focus on patients and their immediate needs.

Both the Knights of Columbus and the Catholic bishops of Iowa are backing the “Collection For Cures,” which aims to raise $10 million for research into rare diseases, regenerative medicine, and personalized cancer treatments.

After he founded the adult stem cell provider Cellular Engineering Technologies in 2005, Moy became aware of key research areas neglected by both the government and the marketplace. He saw the need for a nonprofit enterprise that could fill these scientific and technological gaps.

In 2006, Moy established the John Paul II Stem Cell Research Institute in Iowa City, as a grassroots effort of Catholic laity and others concerned with the future of ethical biotechnology.

“The goal of the institute is to identify and solve some of the major deficiencies in this country – one of which is the ethical issues surrounding embryonic stem cells,” he noted.

In addition to its pro-life ethical basis, Moy's work stands out in the field for other reasons.

Another distinguishing mark is his interest in treating and curing “orphan diseases.” The term denotes  thousands of serious but rare ailments that fail to attract research dollars, because of the relatively small number of sufferers.

Many of these rare diseases may be treatable with existing FDA-approved drugs. But drug companies have little commercial incentive to discover these applications, particularly when extensive regulatory burdens are factored in to the equation.

Moy, however, wants to use disease-specific, non-embryonic stem cell lines to test the effect of existing drugs and therapies on these unusual ailments. The method saves both money and time over research protocols that would involve testing on animals before moving on to human tissue.

This approach streamlines the research process, often using patients' own cells to investigate possible cures and treatments. In 2010, the National Institutes of Health reported progress toward treatment of the fatal disease Niemann-Pick Type C, based on work with cells from the institute.

Along with its work on “orphan diseases,” the John Paul II Stem Cell Research Institute is also using adult cells to investigate new methods of cancer treatment, and ethical forms of the regenerative possibilities more often associated with stem cell research.

Development director Kim Lehman, who served as president of Iowa Right To Life before taking a full-time position with the institute, told CNA that the goal was “to do research that lands at the bedside of the patient, not just in the petri dish so that an article can be written.”

“That's our objective – to have therapies that are able to reach the patient,” Lehman said.

The program works by soliciting $1,000 yearly pledges from Catholic parishes. Lehman explained that the backing of larger donors allows the institute to direct all of the pledged money directly to research.

Dr. Moy, meanwhile, not only hopes to find new ethical cures and treatments, but also to change the direction of U.S. biotechnology research, by demonstrating the potential that other countries already recognize in adult stem cells.

Globally, he noted, over 90 percent of all stem cell trials involve adult cells rather than those derived from embryos. But only a quarter of these trials are taking place in the U.S., where Moy believes adult stem cells have been marginalized due to “hype” and controversy over embryonic research.

Although the institute is largely focused on the “niche” areas of cancer treatment and rare diseases, the researcher believes that “the outcomes of what we do will have a broader appeal and application” to the fields of medicine and biotechnology in the future.

Ads by AdsLiveMedia(What's this?)

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages

RESOURCES »

Ads by Google (What's this?)
Ads by Google

Featured Videos

Little Sisters of the Poor press conference in Denver
Little Sisters of the Poor press conference in Denver
Family thrilled to see Pope Francis in Istanbul
Syrian Refugee, Sara, 14, Before Meeting Pope
Ebola orphans thousands of children in West Africa
One year after Haiyan: Philippines rebuilds homes, lives
An Indian contribution to the Vatican's Synod on the Family
Christ Cathedral CNA video Sept 2014
Alejandro Bermudez of CNA accepts ice bucket challenge
'The Real Albania,' remembering those who fled
Pope Francis in Albania, "one of the most important visits of the post-communist era in Albania"
Pope Francis greets paralyzed man who risked all to see him
Franciscans on the banks of the Tiber in Rome, working for the New Evangelization
Pilgrimage from Czech Republic to Assisi and Rome for intentions
Testimony of young Indian who met Pope in Korea
Preparations of the Closing Mass of 6th Asian Youth Day
Missionary of Charity, Korea
Testimony of Christian Love during Pope's Visit to Korea
Religious Sisters in South Korea react to Pope Francis kissing a baby
Warm atmosphere during Holy Mass at Daejeon World Cup Stadium
Images inside Pope Francis flight to South Korea
Dec
18

Liturgical Calendar

December 18, 2014

Advent Weekday

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Mt 21:23-27

Gospel
Date
12/15/14
12/14/14
12/13/14

Daily Readings


First Reading:: Jer 23: 5-8
Gospel:: Mt 1: 18-25

Saint of the Day

St. Romuald »

Saint
Date
12/15/14

Homily of the Day

Mt 21:23-27

Homily
Date
12/15/14
12/14/14
12/13/14